Allergan PLC | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
8,678
13,062
12,688
14,571
15,941
15,787
Cost of Goods Sold (COGS) incl. D&A
5,461
8,884
8,094
8,319
9,496
8,813
Gross Income
3,217
4,178
4,594
6,251
6,445
6,974
SG&A Expense
2,494
4,205
5,546
6,916
6,730
6,642
EBIT
722
27
-
664
285
333
Unusual Expense
1,124
1,020
1,877
1,006
5,193
3,707
Non Operating Income/Expense
8
189
272
64
3,880
2,617
Interest Expense
240
485
1,458
1,296
1,096
911
Pretax Income
638
1,712
4,548
2,832
10,386
6,857
Income Tax
113
82
1,606
1,897
6,670
1,771
Consolidated Net Income
751
1,630
2,942
935
3,716
5,086
Net Income
750
1,631
2,946
941
3,723
5,096
Net Income After Extraordinaries
750
1,631
9,807
16,856
3,320
5,096
Net Income Available to Common
750
1,631
3,683
14,695
4,404
5,143
EPS (Basic)
5.27
7.42
10.01
38.18
13.19
15.26
Basic Shares Outstanding
142
220
368
385
334
337
EPS (Diluted)
5.27
7.42
10.01
38.18
13.19
15.26
Diluted Shares Outstanding
142
220
368
385
334
337
EBITDA
1,767
2,802
4,617
5,960
7,084
7,081
Non-Operating Interest Income
5
9
11
70
68
45
Minority Interest Expense
-
1
4
6
7
10
Equity in Affiliates (Pretax)
6
-
-
-
-
-
Preferred Dividends
-
-
232
278
278
46
About Allergan
View Profile
